Ebba U. Kurz

University of Calgary — Canada

Biochemistry, Genetics and Molecular Biology · Life Sciences

18h-index4.8kcitations33works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer therapeutics and mechanisms(8), DNA Repair Mechanisms(5), Drug Transport and Resistance Mechanisms(5), Synthesis and Biological Evaluation(5), Carcinogens and Genotoxicity Assessment(4)

Publications32 total

Toxicity of Haloacetonitrile Mixtures to a Normal Tissue-Derived Human Cell Line: Are They Additive, Synergistic, or Antagonistic?
Environmental Science & Technology Letters·2025· 4 cited
Toxicity of Haloacetonitrile Mixtures in a Normal Tissue-Derived Human Cell Line: Are they additive, synergistic, or antagonistic?
2024Open Access
The analysis of protein recruitment to laser microirradiation-induced DNA damage in live cells: Best practices for data analysis
DNA repair·2023· 4 cited
Pay-To-Pass: Evolving Online Systems That Undermine the Integrity of Student Work
Ethics and integrity in educational contexts·2022· 5 citedOpen Access
Pay-to-Pass: Emerging On-Line Services that are Undermining the Integrity of Student Work
Canadian Perspectives on Academic Integrity·2021Open Access
Inquiry-Based Learning (IBL) as a Driver of Curriculum: A Staged Approach
Papers on postsecondary learning and teaching.·2019· 15 citedOpen Access
Experiential learning through independent study: a broadly accessible, high impact practice
2019
M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma
Neuro-Oncology·2016· 53 citedOpen Access
Fostering Deep Learning, Engagement, and Critical Thinking
PRISM (University of Calgary)·2015· 1 citedOpen Access
In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells
Neuro-Oncology·2015· 30 citedOpen Access
Structural determinants of the catalytic inhibition of human topoisomerase IIα by salicylate analogs and salicylate-based drugs
Biochemical Pharmacology·2014· 4 cited
Salicylate, a Catalytic Inhibitor of Topoisomerase II, Inhibits DNA Cleavage and Is Selective for the α Isoform
Molecular Pharmacology·2013· 33 cited
Abstract LB-140: Targeting brain tumour initiating cells using a dual-pronged approach of oncolytic virotherapy and chemotherapeutics
Cancer Research·2012
Abstract C39: Catalytic inhibition of human DNA topoisomerase II α by salicylate and related nonsteroidal anti-inflammatory drugs
Cancer Research·2011
Sodium salicylate is a novel catalytic inhibitor of human DNA topoisomerase II alpha
Biochemical Pharmacology·2010· 21 cited
Altered chloride homeostasis removes synaptic inhibitory constraint of the stress axis
Nature Neuroscience·2009· 228 cited
Activation of ATM by DNA Damaging Agents
2005
Doxorubicin Activates ATM-dependent Phosphorylation of Multiple Downstream Targets in Part through the Generation of Reactive Oxygen Species
Journal of Biological Chemistry·2004· 252 citedOpen Access
Activation of ATM by DNA Damaging Agents
2004
DNA damage-induced activation of ATM and ATM-dependent signaling pathways
DNA repair·2004· 468 cited
page 1 of 2Next →

Frequent Co-authors

Susan P.C. Cole(5), Susan P. Lees‐Miller(5), Roger G. Deeley(4), David J. Kroll(4), Jason T. Bau(4), Aaron A. Goodarzi(3), Brienne McKenzie(3), Franz J. Zemp(3), Grant McFadden(3), Peter Forsyth(3), Gabu Bhardwaj(2), Caroline E. Grant(2), Kelly B. Leader(2), Alexandra Pisklakova(2), Xueqing Lun(2), Rajappa S. Kenchappa(2), Ronda K. Baker(2), Aru Narendran(2), Donna M. Slater(2), Nancy Chibry(2)